Edition:
United States

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

216.52USD
23 May 2018
Change (% chg)

$-1.34 (-0.62%)
Prev Close
$217.86
Open
$217.00
Day's High
$218.40
Day's Low
$215.70
Volume
285,867
Avg. Vol
392,812
52-wk High
$226.34
52-wk Low
$170.07

Chart for

About

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical... (more)

Overall

Beta: 1.08
Market Cap(Mil.): $77,069.81
Shares Outstanding(Mil.): 398.89
Dividend: 0.15
Yield (%): 0.31

Financials

  TMO.N Industry Sector
P/E (TTM): 33.65 148.43 32.75
EPS (TTM): 5.74 -- --
ROI: 5.81 9.37 14.38
ROE: 10.40 14.69 16.07

BRIEF-Thermo Fisher Scientific Sets Quarterly Cash Dividend Of $0.17 Per Share

* SETS QUARTERLY CASH DIVIDEND OF $0.17PER SHARE Source text for Eikon: Further company coverage:

May 24 2018

BRIEF-Omega Advisors Takes Share Stake In UnitedHealth, Bristol-Myers Squibb

* OMEGA ADVISORS DISSOLVES SHARE STAKE IN AMERICAN AIRLINES - SEC FILING

May 15 2018

BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific

* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC

May 01 2018

BRIEF-Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target Test

* THERMO FISHER SCIENTIFIC SIGNS NEW AGREEMENTS TO EXPAND ONCOMINE DX TARGET TEST

May 01 2018

BRIEF-Globalstar To Merge With Metro Fiber Provider Fiberlight And Acquire Other Assets In Stock Transaction

* GLOBALSTAR TO MERGE WITH METRO FIBER PROVIDER FIBERLIGHT AND ACQUIRE OTHER ASSETS IN STOCK TRANSACTION

Apr 25 2018

BRIEF-Thermo Fisher Reports Q1 GAAP Earnings Of $1.43/Share

* CO IS RAISING 2018 REVENUE GUIDANCE TO A NEW RANGE OF $23.62 BILLION TO $23.86 BILLION

Apr 25 2018

BRIEF-Thermo Fisher Scientific CEO Marc Casper's FY 2017 Total Compenstion Was $22.3 Mln VS $17.8 Mln

* THERMO FISHER SCIENTIFIC CEO MARC N. CASPER'S FY 2017 TOTAL COMPENSTION WAS $22.3 MLN VS $17.8 MLN - SEC FILING Source text: (https://bit.ly/2HqYMsM) Further company coverage:

Apr 10 2018

BRIEF-Ortho Clinical Diagnostics And Thermo Fisher Scientific Agree To Deliver 14 Assays For Use On Ortho's Vitros Systems

* ORTHO CLINICAL DIAGNOSTICS AND THERMO FISHER SCIENTIFIC AGREE TO DELIVER 14 ASSAYS FOR USE ON ORTHO'S VITROS® SYSTEMS

Apr 05 2018

BRIEF-Biocept And Thermo Fisher Scientific Enter Into Technology And Commercial Collaboration

* BIOCEPT AND THERMO FISHER SCIENTIFIC ENTER INTO TECHNOLOGY AND COMMERCIAL COLLABORATION

Mar 28 2018

BRIEF-Thermo Fisher Scientific Acquires Integenx

* THERMO FISHER SCIENTIFIC ACQUIRES INTEGENX, PROVIDER OF LEADING RAPID DNA TECHNOLOGY FOR HUMAN IDENTIFICATION

Mar 16 2018

Earnings vs. Estimates